Personalis/$PSNL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Personalis
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Ticker
$PSNL
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
229
ISIN
US71535D1063
Website
Personalis Metrics
BasicAdvanced
$414M
-
-$1.23
1.84
-
Price and volume
Market cap
$414M
Beta
1.84
52-week high
$7.20
52-week low
$1.14
Average daily volume
686K
Financial strength
Current ratio
6.906
Quick ratio
6.579
Long term debt to equity
16.841
Total debt to equity
21.812
Interest coverage (TTM)
-1,560.07%
Management effectiveness
Return on assets (TTM)
-17.90%
Return on equity (TTM)
-51.25%
Valuation
Price to revenue (TTM)
3.746
Price to book
2
Price to tangible book (TTM)
2
Price to free cash flow (TTM)
-6.873
Growth
Revenue change (TTM)
15.57%
Earnings per share change (TTM)
-34.90%
3-year revenue growth (CAGR)
2.39%
3-year earnings per share growth (CAGR)
-12.32%
What the Analysts think about Personalis
Analyst ratings (Buy, Hold, Sell) for Personalis stock.
Personalis Financial Performance
Revenues and expenses
Personalis Earnings Performance
Company profitability
Personalis News
AllArticlesVideos
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
Business Wire·6 days ago
Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Personalis stock?
Personalis (PSNL) has a market cap of $414M as of May 28, 2025.
What is the P/E ratio for Personalis stock?
The price to earnings (P/E) ratio for Personalis (PSNL) stock is 0 as of May 28, 2025.
Does Personalis stock pay dividends?
No, Personalis (PSNL) stock does not pay dividends to its shareholders as of May 28, 2025.
When is the next Personalis dividend payment date?
Personalis (PSNL) stock does not pay dividends to its shareholders.
What is the beta indicator for Personalis?
Personalis (PSNL) has a beta rating of 1.84. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.